Cetrorelix Acetate
GnRH antagonist for IVF applications. Flexible administration schedule with immediate LH suppression, enabling personalized ovarian stimulation protocols in assisted reproduction.
Cetrorelix acetate is a synthetic decapeptide and a potent GnRH (Gonadotropin-Releasing Hormone) receptor antagonist. It competitively blocks GnRH receptors on the pituitary gonadotroph cells, rapidly suppressing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) without the initial flare-up effect characteristic of GnRH agonists. This makes it particularly valuable in assisted reproductive technology (ART) protocols.
| Parameter | Specification |
| CAS | 120287-85-6 |
| Molecular Formula | C₇₀H₉₂ClN₁₇O₁₄ |
| Molecular Weight | 1431.06 g/mol |
| Category | GnRH/Reproductive |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | IVF, ovarian stimulation, fertility treatment, LH surge prevention |
| CAS | 120287-85-6 |
|---|---|
| Applications | Assisted Reproduction, Controlled Ovarian Hyperstimulation, Fertility Treatment |
Related products
-
Pramlintide
CAS: 196078-30-5 -
Glucagon HCl
CAS: 16941-32-5Applications: Diabetic Emergency, Glycogenolysis, Hypoglycemia Rescue -
Alarelin
CAS: 79561-22-1Applications: Assisted Reproduction, Endometriosis, Hormone-dependent Tumors, Uterine Fibroids -
Aviptadil
CAS: 40077-57-4Applications: Acute respiratory distress syndrome, ARDS, Lung protection, Pulmonary hypertension, VIP analog